A cross-sectional study on HPV vaccination in German women undergoing excisional CIN therapy and the impact of reimbursement on the acceptance (HPV vacCINe study)
Recruiting
- Conditions
- N87Dysplasia of cervix uteri
- Registration Number
- DRKS00032606
- Lead Sponsor
- MSD Sharp & Dohme GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 1023
Inclusion Criteria
• Subject is scheduled for excisional therapy of CIN
• Permanent coverage by a German statutory or private health insurance since at least one year
• Signed informed consent form (ICF) including data protection consent and signed contact information sheet
Exclusion Criteria
• Subject is not able to read and understand the questionnaires and other study documents (ICF etc.) in German or English language
• Subject is pregnant during the enrollment period
• Subject is not willing to provide contact information
• Subject does not have technical means to complete an electronic questionnaire
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess proportion of =18-year-old previously HPV unvaccinated women undergoing excisional therapy due to CIN that received HPV vaccination contemporary
- Secondary Outcome Measures
Name Time Method To assess to what extent the reimbursement of vaccination influences its acceptance